Add to Cart View Cart/Checkout More Products

Volume 18, 2014 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 2014 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 18 No. 1 January/February 2014 Volume 18, Number 1
Vol. 18 No. 2 March/April 2014 Volume 18, Number 2
Vol. 18 No. 3 May/June 2014 Volume 18, Number 3
Vol. 18 No. 4 July/August 2014 Volume 18, Number 4
Vol. 18 No. 5 September/October 2014 Volume 18, Number 5
Vol. 18 No. 6 November/December 2014 Volume 18, Number 6

Articles
Volume/IssuePageTitle
Vol. 18 No. 1 4 PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year
Vol. 18 No. 1 6 The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Vol. 18 No. 1 14 Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Vol. 18 No. 1 20 Good Enough for America
Vol. 18 No. 1 30 Determination of Risk for Sterile Preparations
Vol. 18 No. 1 35 U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013
Vol. 18 No. 1 38 Marketing
Vol. 18 No. 1 42 Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks
Vol. 18 No. 1 46 Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding
Vol. 18 No. 1 54 Basics of Sterile Compounding: Bubble Point Testing
Vol. 18 No. 1 58 Calculations
Vol. 18 No. 1 60 Aztreonam Injection
Vol. 18 No. 1 61 Bumetanide 0.25-mg/mL Injection
Vol. 18 No. 1 62 Droperidol 2.5-mg/mL Injection
Vol. 18 No. 1 63 Lomustine 100-mg Capsules
Vol. 18 No. 1 64 Neostigmine Bromide 15-mg Capsules
Vol. 18 No. 1 65 Nimodipine 30-mg Capsules
Vol. 18 No. 1 66 Phenobarbital 60-mg Capsules
Vol. 18 No. 1 67 Potassium Chloride 2-mEq/mL Injection
Vol. 18 No. 1 68 Procainamide Hydrochloride 100-mg/mL Injection
Vol. 18 No. 1 69 Vasopressin 20-units/mL Injection
Vol. 18 No. 1 70 The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Vol. 18 No. 1 78 Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C
Vol. 18 No. 1 83 E-Prescribing Errors Identified in a Compounding Pharmacy: A Quality-improvement Project
Vol. 18 No. 1 87 PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services
Vol. 18 No. 2 92 PreScription: Standards vs Opinions
Vol. 18 No. 2 94 A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Vol. 18 No. 2 101 Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective
Vol. 18 No. 2 112 Compounding Practices in Iran
Vol. 18 No. 2 117 IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities
Vol. 18 No. 2 120 Effective Advertisements
Vol. 18 No. 2 123 Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding
Vol. 18 No. 2 131 Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume
Vol. 18 No. 2 137 Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions
Vol. 18 No. 2 140 Calculations
Vol. 18 No. 2 142 Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules
Vol. 18 No. 2 143 Fludarabine Phosphate 25-mg/mL Injection
Vol. 18 No. 2 144 Mecasermin 10-mg/mL Injection
Vol. 18 No. 2 145 Methylprednisolone 40-mg/mL Injection
Vol. 18 No. 2 146 Polymixin B Injection
Vol. 18 No. 2 147 Rocuronium Bromide 10-mg/mL Injection
Vol. 18 No. 2 148 Secretin 4 mcg/mL Injection
Vol. 18 No. 2 149 Selenium 40-mcg/mL Injection
Vol. 18 No. 2 150 Sincalide 1-mcg/mL Injection
Vol. 18 No. 2 151 Testosterone Enanthate 200-mg/mL Injection
Vol. 18 No. 2 152 Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride
Vol. 18 No. 2 159 E-Prescription Errors and Their Resolution in a Community Compounding Pharmacy
Vol. 18 No. 2 162 The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding
Vol. 18 No. 2 169 Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets
Vol. 18 No. 2 175 Recharting Your Vision While Remaining True to Your Charter
Vol. 18 No. 3 180 PreScription: Déjà Vu All Over Again
Vol. 18 No. 3 182 A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Vol. 18 No. 3 190 Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice
Vol. 18 No. 3 203 Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation
Vol. 18 No. 3 208 The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Vol. 18 No. 3 210 Marketing: Effective Use of Advertisements on Your Website
Vol. 18 No. 3 213 Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1
Vol. 18 No. 3 222 Quality Control Analytical Methods: Establishing Powder-handling Workflow Practices and Standard Operating Procedures: Compounding Pharmacy and Safety
Vol. 18 No. 3 228 Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams
Vol. 18 No. 3 231 Calculations
Vol. 18 No. 3 232 Atorvastatin 10-mg or 20-mg Capsules
Vol. 18 No. 3 233 Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules
Vol. 18 No. 3 234 Bupivacaine Hydrochloride 0.5% Injection
Vol. 18 No. 3 235 Butorphanol Tartrate 10-mg/mL Nasal Spray
Vol. 18 No. 3 236 Dibucaine 1% Ointment
Vol. 18 No. 3 237 Lidocaine Hydrochloride 1% Injection
Vol. 18 No. 3 238 Methotrexate 2.5-mg Capsules
Vol. 18 No. 3 239 Naproxen 25-mg/mL Oral Suspension
Vol. 18 No. 3 240 Tamoxifen 10-mg or 20-mg Capsules
Vol. 18 No. 3 241 Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules
Vol. 18 No. 3 242 Examination of the Order of Incubation for the Recovery of Bacteria and Fungi from Pharmaceutical-grade Cleanrooms
Vol. 18 No. 3 248 Investigation of Physical and Chemical Stability of an Ointment with Herbals
Vol. 18 No. 3 253 Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Vol. 18 No. 3 256 Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Vol. 18 No. 3 262 PostScription: The Fourth Annual Student Pharmacist Compounding Competition: Building Future Leaders in the Industry
Vol. 18 No. 4 268 PreScription: Challenging Times
Vol. 18 No. 4 270 Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety
Vol. 18 No. 4 278 Compounded Pain Formulations: What is the Evidence?
Vol. 18 No. 4 287 Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis
Vol. 18 No. 4 293 Color Additives: Legislative Perspective in the United States, Europe, Australia, and India
Vol. 18 No. 4 302 400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill
Vol. 18 No. 4 305 Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Vol. 18 No. 4 313 Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Vol. 18 No. 4 318 Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Vol. 18 No. 4 320 Calculations
Vol. 18 No. 4 322 Atracurium Besylate 10-mg/mL Injection, Preserved
Vol. 18 No. 4 323 Barium Sulfate Suspension
Vol. 18 No. 4 324 Calcitriol 1-mcg/mL Injection
Vol. 18 No. 4 325 Chloramphenicol 100-mg/mL Injection
Vol. 18 No. 4 326 Chlorothiazide 50-mg/mL Oral Suspension
Vol. 18 No. 4 327 Choline Magnesium Trisalicylate Liquid
Vol. 18 No. 4 328 Denileukin Diftitox 150-mcg/mL Injection
Vol. 18 No. 4 329 Indigo Carmine Injection
Vol. 18 No. 4 330 Propranolol Hydrochloride 1-mg/mL Injection
Vol. 18 No. 4 331 Zinc 1-mg/mL Injection
Vol. 18 No. 4 332 Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Vol. 18 No. 4 341 Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding
Vol. 18 No. 4 345 Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Vol. 18 No. 4 348 Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Vol. 18 No. 4 351 PostScription: Responsibilities of a Compounding Pharmacist
Vol. 18 No. 5 356 PreScription: What is a Compounding Pharmacist?
Vol. 18 No. 5 358 Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Vol. 18 No. 5 366 To Compound or Not to Compound: A Veterinary Transdermal Discussion
Vol. 18 No. 5 370 Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Vol. 18 No. 5 379 Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Vol. 18 No. 5 382 Health Care in Belarus in the 19th and 20th Centuries
Vol. 18 No. 5 392 Compounding Practices in a Portuguese Community Pharmacy
Vol. 18 No. 5 397 Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know
Vol. 18 No. 5 401 Basics of Compounding: Tips and Hints, Part 5: Facilities and Equipment
Vol. 18 No. 5 406 Marketing: Tips on Dealing With a Healthcare Practititioner's No-Rep Policy
Vol. 18 No. 5 407 Calculations
Vol. 18 No. 5 408 Azithromycin 100-mg/mL Injection
Vol. 18 No. 5 409 Bacitracin Topical Ointment
Vol. 18 No. 5 410 Dexpanthenol 250-mg/mL Injection
Vol. 18 No. 5 411 Ephedrine Sulfate 50-mg/mL Injection
Vol. 18 No. 5 412 Fluorescein 100-mg/mL Injection
Vol. 18 No. 5 413 Indocyanine green 2.5-mg/mL Injection
Vol. 18 No. 5 414 Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution
Vol. 18 No. 5 415 Sulfamethoxazole and Trimethoprim Oral Solution
Vol. 18 No. 5 416 Sumatriptan Succinate 12-mg/mL Injection
Vol. 18 No. 5 417 Tranexamic Acid 100-mg/mL Injection
Vol. 18 No. 5 418 Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Vol. 18 No. 5 427 Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Vol. 18 No. 5 432 Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers
Vol. 18 No. 5 438 PostScription: The Future of Veterinary Compounding
Vol. 18 No. 6 444 PreScription: "Named Formulas" Database Available
Vol. 18 No. 6 446 Depyrogenation Options for the Compounding Cleanroom
Vol. 18 No. 6 456 Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date
Vol. 18 No. 6 462 Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Medications in a Rural Setting: A Case Study from the Delmarva Peninsula
Vol. 18 No. 6 470 Compounding Legislation: Focus Shifts to States
Vol. 18 No. 6 475 Quality Control: Can Compounding Pharmacy Learn from the Automotive Industry?
Vol. 18 No. 6 479 Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Vol. 18 No. 6 486 Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous
Vol. 18 No. 6 490 Marketing: Using Facebook to Market Your Compounding Pharmacy
Vol. 18 No. 6 492 Calculations
Vol. 18 No. 6 494 Clarithromycin 250-mg or 500-mg Capsules
Vol. 18 No. 6 495 Dexmedetomidine 100 mcg/mL Injection
Vol. 18 No. 6 496 Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules
Vol. 18 No. 6 497 Leucovorin 10-mg/mL Injection
Vol. 18 No. 6 498 Levocarnitine 200-mg/mL Injection
Vol. 18 No. 6 499 Methazolamide 25-mg or 50-mg Capsules
Vol. 18 No. 6 500 Methylene Blue 10-mg/mL Injection
Vol. 18 No. 6 501 Methylphenidate Hydrochloride 10-mg Capsules
Vol. 18 No. 6 502 Oxacillin Sodium 167-mg/mL Injection
Vol. 18 No. 6 503 Tamsulosin Hydrochloride 0.2-mg Capsules
Vol. 18 No. 6 504 Skin Penetration and Antinociception of Topical Gabapentin Formulations
Vol. 18 No. 6 512 In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Vol. 18 No. 6 516 Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils
Vol. 18 No. 6 520 High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products
Vol. 18 No. 6 526 PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future